Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Follitropin beta 300iu injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Follitropin beta 600iu injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary follicle stimulating hormone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Follitropin alfa 600units/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatrem 5mg/vial injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatrem 10 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Follitropin beta 75iu/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Follitropin alfa 150units/amp injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Follitropin alfa 75iu/amp powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10mg/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10mg/2mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.6mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.2mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 2mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.8mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 2.0mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 13.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.5mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.4mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.2mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.4mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.6mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.2mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.8mg/unt powder (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.6mg/unt powder (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.44mg/unit powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.8mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.0mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.4mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary follicle stimulating hormone 150 unit and pituitary luteinising hormone 150 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anterior pituitary hormone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Follitropin beta 900iu injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Recomb human follicle stim horm alpha 1200iu powder and solvent for injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cosyntropin 50mcg/mannitol 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sermorelin acetate 0.5mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 12mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.6mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 15mg/1.5mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5.0mg/1.5mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sermorelin acetate 1.0mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 6mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sermorelin acetate 50mcg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10.0mg/1.5mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anterior pituitary hormone |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by pituitary hormone |
Causative agent (attribute) |
True |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Anterior pituitary hormone |
Is a |
True |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary hormone allergy |
Causative agent (attribute) |
True |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Corticotropic agent |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatotrophin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Melanocyte stimulating hormone analog |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prolactin |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human follicle stimulating hormone |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by somatotropin |
Causative agent (attribute) |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional thyrotrophic hormone poisoning |
Causative agent (attribute) |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental somatotrophin poisoning |
Causative agent (attribute) |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional somatotrophin poisoning |
Causative agent (attribute) |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thyrotrophic hormone poisoning |
Causative agent (attribute) |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental thyrotrophic hormone poisoning |
Causative agent (attribute) |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thyrotrophic hormone poisoning of undetermined intent |
Causative agent (attribute) |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human menopausal gonadotropin |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by anterior pituitary hormone (disorder) |
Causative agent (attribute) |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary follicle stimulating hormone |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lipotropin |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|